Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?

J Rheumatol. 2004 May;31(5):986-91.

Abstract

Objective: To evaluate serum levels of osteoprotegerin (OPG) and receptor activator of nuclear factor kB-ligand (RANK-L) in patients with juvenile idiopathic arthritis (JIA); to correlate these values with disease activity variables, radiological bone damage, and bone mass; and to correlate OPG gene polymorphisms with bone mass.

Methods: Eighty-four patients (66 girls and 18 boys) with JIA and 40 sex and age-matched controls were enrolled. Serum OPG and RANK-L were measured using an enzyme-linked immunosorbent assay. OPG genotyping was performed by polymerase chain reaction.

Results: Patients with JIA had significantly higher levels of serum OPG than controls (p = 0.001) and lower levels of RANK-L in comparison with controls (p = 0.0003). The OPG/RANK-L ratio in patients was higher than in controls (p = 0.004). No significant correlations were found between disease duration, erythrocyte sedimentation rate, and C-reactive protein values with either OPG or RANK-L serum levels. A significant difference in serum OPG levels (but not in RANK-L) was found between patients with and without erosions (p = 0.008). No correlation was found between OPG and RANK-L levels and bone mass (DXA Z scores). A higher prevalence of OPG CC genotype was found in both patients (65.4%) and controls (82.5%) (p = 0.006). Subjects with CC genotype had a higher lumbar spine bone mineral density (LS-BMD).

Conclusion: We evaluated for the first time levels of OPG and RANK-L in children with JIA. The higher OPG/RANK-L ratio in JIA might be the result of a compensatory production of OPG. The presence of the T allele of the OPG gene appears to be associated with low BMD.

MeSH terms

  • Arthritis, Juvenile / blood*
  • Arthritis, Juvenile / genetics
  • Arthritis, Juvenile / pathology
  • Blood Sedimentation
  • Bone Density
  • Bone Resorption / metabolism*
  • Bone Resorption / pathology
  • Carrier Proteins / blood*
  • Child
  • Child, Preschool
  • DNA / analysis
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Glycoproteins / blood*
  • Glycoproteins / genetics
  • Humans
  • Joints / metabolism*
  • Joints / pathology
  • Male
  • Membrane Glycoproteins / blood*
  • Osteoprotegerin
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Receptors, Cytoplasmic and Nuclear / blood*
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Tumor Necrosis Factor / blood*
  • Synovial Fluid / metabolism
  • Time Factors

Substances

  • Carrier Proteins
  • Glycoproteins
  • Membrane Glycoproteins
  • Osteoprotegerin
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Tumor Necrosis Factor
  • TNFRSF11A protein, human
  • TNFRSF11B protein, human
  • TNFSF11 protein, human
  • DNA